Cell and Gene Therapy Business Outlook: Volume 1, Issue 3
Don't miss our new twice-monthly publication dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following:
- Market Sizing and Forecasting of CAGT Markets
- Executive News Summaries
- Deals Between CAGT Companies Tracked
- Financing
- Trends in the Industry
- Important Science That Will Shape Tomorrow’s Business
- Company Profiling and Quarterly Results Summaries
- Updates on Pipelines and Important Clinical Trials
- Cell and Gene Therapy Tools
- Cell and Gene Therapy CMOs
- And More
Table of Contents
- About CGT Business Outlook
-
Market Analysis
-
Focus on Ophthalmology
- Overview of Eye Diseases
- Market Outlook
- Products on the Market
- Products in Development
- Market Size and Growth
- Regional Market
- Top Company Briefs
- Conclusion
-
Focus on Ophthalmology
-
Executive News Brief
- Recent developments in cell and gene therapy
- Cell and Gene Therapy Market Financing
-
Cell and Gene Therapy Market News and News Analysis
- Intellia and Regneron Announce CRISPR/Cas9 Breakthrough
- Shape Therapeutics Takes Aim at RNA-based Therapies
- Prime Medicine Launches with $315 Million in Financing
- The Cell and Gene Therapy Supplies Market: Growth Driven by Clinical Trials
- Recent CGT Deal Activity